Skip to content

Prevent Cancer- Greenville

Prevent Cancer-Greenville: A Center for Cancer Prevention and Wellness Research Project

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04947098
Acronym
CCPW
Enrollment
1000
Registered
2021-07-01
Start date
2018-11-08
Completion date
2029-11-08
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, High-Risk Cancer

Brief summary

Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.

Detailed description

Participants' personal history, lifestyle behaviors and blood, urine, and cheek swab specimens will be used to detect changes or trends that might put them at risk for developing cancer. Some individuals may be at an above average risk of cancer due to lifestyle, family background, personal genetic makeup, or environmental exposures. This will be determined by a process called risk stratification. Risk stratification involves looking at all health-related aspects of a person, determining their individualized risk through screening, and educating them on measures to reduce potential for disease. Participants will complete a yearly health assessment which includes measurements for nutrition, activity, individual risk factors and body composition, including weight height and a special scale which measures fluid and fat.

Interventions

None listed

Sponsors

Prisma Health-Upstate
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older

Design outcomes

Primary

MeasureTime frameDescription
Assess changes in alcohol useYearly follow up for 10 yearsParticipants will be educated on healthy lifestyle habits and alcohol use will be assessed yearly.
Assess changes in nutrition by nutrition questionnaireYearly follow up for 10 yearsNutrition will be assessed yearly by a questionnaire based on nutrition recommendations from the American Institute for Cancer Research and the U.S. Department of Health and Human Services.
Assess changes in physical activity by physical activity questionnaireYearly follow up for 10 yearsPhysical activity will be assessed yearly a questionnaire based on physical activity recommendations from the U.S. Department of Health and Human Services.
Assess changes in smoking habitsYearly follow up for 10 yearsParticipants will be educated on healthy lifestyle habits and smoking habits will be assessed yearly.
Assess hereditary risk through family history reviewYearly follow up for 10 yearsEach participant's family history will be reviewed to make recommendations for screening or genetic testing based on National Comprehensive Cancer Network guidelines.
Assess lifetime breast cancer risk through the Tyrer-Cuzick version 8 breast risk evaluation toolYearly follow up for 10 yearsParticipants' breast cancer risk will be assessed using the Tyrer-Cuzick breast cancer risk model. Participants will be referred to appropriate clinics if lifetime risk is greater than 20 percent.
Assess 5- year breast cancer risk through the GAIL breast risk evaluation toolYearly follow up for 10 yearsParticipants' breast cancer risk will be assessed using the National Cancer Institute's GAIL model. Participants will be referred to appropriate clinics if GAIL 5 year risk is greater than 1.7 percent.
Early detection of malignancies through screeningYearly follow up for 10 yearsParticipants will be educated on screening recommendations by the American Cancer Society. Malignancies will be recorded yearly if found by recommended screenings.
Assess changes in fat mass by SOZO measurementsYearly follow up for 10 yearsBody composition will be assessed yearly by measurements taken from the SOZO device which uses bioimpedance spectroscopy to measure fat mass.
Assess changes in muscle mass by SOZO measurementsYearly follow up for 10 yearsBody composition will be assessed yearly by measurements taken from the SOZO device which uses bioimpedance spectroscopy to measure muscle mass.

Secondary

MeasureTime frameDescription
Assess changes in quality of life by the 5-level EuroQol-5D version (EQ-5D-5L) questionnaireYearly follow up for 10 yearsQuality of life will be assessed yearly by the EQ-5D-5L questionnaire. Participants' will self-report their health on a scale numbered 0-100. 100 means the best health you can imagine and 0 means the worst health you can imagine.

Countries

United States

Contacts

CONTACTPatricia Wilson, MSN Ed. OCN ONNCG
ccpw@prismahealth.org864-455-4897
PRINCIPAL_INVESTIGATORJoe Stephenson, MD

Prisma Health-Upstate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026